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Clinicians can no longer afford to be unaware of the
advances made in molecular biology and the impact these are
making on their subject. Indeed, this is the case for every
aspect of medicine and surgery. One of the problems with
molecular genetics is that for many clinicians its importance
and relevance to clinical medicine has grown so fast that
what one learnt at medical school is now inadequate for an
understanding of the subject today. Therefore a clearer
understanding and appreciation of the subject must be
obtained at a later date. Unfortunately, by this stage one's
knowledge of biochemistry, cell biology and genetics is also
in need of a little updating, so any book that brings these
subjects together between its covers, as well as demonstrating
their application to Medicine, is welcome.
Apart from the obvious potential therapeutic values of
gene therapy and genetically engineered enzyme replacement,
molecular biology is contributing a vast resource to clinical
diagnostics. Applications vary from the elucidation ofgenetic
disorders affecting the foetus, to the detection of M. tuber-
culosis DNA in sputum by the Polymerase Chain Reaction
(PCR). However, to appreciate the value of molecular bio-
logy in these applications it is important to understand the
techniques fully and also be aware of their limitations. Before
incorporating molecular genetic techniques into professional
practice, clinicians will want to feel informed about basic
molecular biology, and comfortable with its language and
'jargon'. So where does the clinician look? He or she could
certainly do worse than start with Professor Brock's user-
friendly introduction, which also includes much basic molec-
ular biology. There is no shortage of books on the matter.
Most are large and aim to be comprehensive, though this is
often difficult to achieve with the science advancing so
rapidly. Many are pure molecular biology or cell biology
textbooks, while others cover mainly medical genetics. Many
books, however with some exceptions, suffer from size and so
will probably not leave the bookshelf. Professor Brock's
book is conveniently small in size and only 289 pages long, a
blessing for its target readership of busy people and medical
students (who always like a short book). This book however
is not short on information and comprehensively covers the
field, from classical Mendelian genetics to gene therapy. It is
as up to date as can be expected with the most recent
references being from 1992. Areas of impending interest are
also highlighted, an example being the increasing recognition
that repeat sequences are not just 'junk DNA', but have the
ability to cause inherited diseases. This is illustrated by a
discussion of the Fragile-X-Syndrome. No doubt in the
second edition Huntington's Disease will provide an equally
good example for the trinucleotide repeat problem. Gene
tracking is clearly described with relevant examples and Lod
score (second nature to geneticists, merely an abbreviation to
non geneticists) are lucidly explained. Professor Brock does
not shy away from describing methodology which includes
useful descriptions of the omnipresent PCR reaction, DNA
sequencing, Pulse Field Gel Electrophoresis, and a very
inviting diagram of Subtractive Hybridization (not quite as
easy as it looks). Cytogenetics, mapping techniques, including
Fluorescent in situ Hybridization (FISH), and imprinting are
well covered. Thankfully a description of numerous chromo-
somal abnormalities with their resultant clinical phenotypes
is avoided. There are also up to date accounts of cancer
genetics and the genetics of multifactorial disorders. The last
chapter is dedicated to current and future developments
which involves a brief introduction to the controversial and
vastly expensive Human Genome Mapping Project, and the
use or possible abuse of gene therapy. There is also a section
discussing the avoidance of genetic disease including a con-
sideration of the ethical issues raised by the investigation of
genetic disease at both pre- and post-conception stages.
The book is well indexed and interesting suggestions are
made for further reading. It would have been nice to have
seen a few more colour plates, but with the radiographic
nature of many molecular biology techniques, the subject
lends itself well to black and white illustrations which are
liberally used. The only serious criticism that I have is that I
found the front cover rather uninspiring. This is unfortunate
because beyond the cover, the content is enjoyable to read
and will help clinicians to come to grips with the molecular
genetic advances occurring in their speciality.
A.P. Cahn
Ovarian Cancer
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Yet another book about ovarian cancer, but does it represent
a useful contribution? Yes, I believe it does, and one which
will be of value both to oncologists in training and to
specialists in this field. The editors have produced a well-
structured work covering the basic science, histopathology
and clinical management of ovarian cancer. There is a clear
editorial policy to take the reader back to square one in each
area. The basic science section includes excellent reviews on
cancer genetics, oncogenes and mechanisms of chemotherapy
resistance in the treatment of ovarian cancer. These are easy
to read and a handy source of references.
Histopathology occupies a significant portion of the book,
which is justified by the complexity of the subject. Further
details are covered in the clinical chapters on germ cell
tumours, stromal tumours and in an excellent review of
tumours of low malignant potential, otherwise known as
'borderline tumours'.
There is some needless repetition, such as the presence of
two chapters on cancer genetics and two covering intra-
peritoneal chemotherapy, which, given recent waning of
enthusiasm for this approach, seems excessive. There are
also, perhaps inevitably, some gaps. Controversial issues,
such as the importance of dose intensity in this disease, are
discussed, including the potential for dose escalation using
haemopoietic growth factors. However, there is no mention
of peripheral blood stem cells as an alternative to bone
marrow transplantation, and the importance of carboplatin
dosing according to renal function fails to receive adequate
attention. The role of the tumour marker CA-125, while
mentioned frequently with regard to surgical management, is
seemingly ignored in relation to chemotherapy. This is sur-
prising, given the evidence that the rate of marker fall in
response to chemotherapy yields prognostic information, in
addition to the potential use of CA-125 as a surrogate
marker of response and a sensitive early indicator of recur-
rent disease.
I liked the use of 'case histories' in the chapter on quality
of life considerations, which was thought-provoking and well
argued. For a disease in which much of the treatment is
necessarily palliative in intent, it is certainly right that we be
encouraged to think in this way. Major surgical controver-
sies, such as the potential value of second-look laparotomy
and cytoreductive surgery, are well covered, indeed each has
a chapter to itself. It is acknowledged that such procedures